Role Played by Biochemical and Hematological Parameters in the Prediction of Cardiovascular Risk

References (56)

1. 1 Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015 [DOI]
2. 2 Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study [DOI]
3. 3 Prediction of Lifetime Risk for Cardiovascular Disease by Risk Factor Burden at 50 Years of Age [DOI]
4. 4 Neutrophil-to-lymphocyte ratio, past, present and future perspectives [DOI]
5. 5 What is the normal value of the neutrophil-to-lymphocyte ratio? [DOI]
6. 6 A Brief Review of Cardiovascular Diseases, Associated Risk Factors and Current Treatment Regimes [DOI]
7. 7 Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study [DOI]
8. 8 Neutrophil Lymphocyte Ratio and Cardiovascular Disease Risk: A Systematic Review and Meta-Analysis [DOI]
9. 9 An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study [DOI]
10. 10 The AST/ALT ratio as an indicator of cirrhosis in patients with PBC [DOI]
11. 11 Red blood cell distribution width and cardiovascular diseases. [DOI]
12. 12 Lipid parameters for measuring risk of cardiovascular disease [DOI]
13. 13 Neutrophilia Predicts Death and Heart Failure After Myocardial Infarction [DOI]
14. 14 Patterns and causes of liver involvement in acute dengue infection [DOI]
15. 15 Platelet to Lymphocyte Ratio in Cardiovascular Diseases: A Systematic Review [DOI]
16. 16 Comparison of the Framingham Risk Score, SCORE and WHO/ISH cardiovascular risk prediction models in an Asian population [DOI]
17. 17 Relative lymphocyte count: A prognostic indicator of mortality in elderly patients with congestive heart failure [DOI]
18. 18 Comparison of different cardiovascular risk score calculators for cardiovascular risk prediction and guideline recommended statin uses [DOI]
19. 19 Evaluation of complete blood count parameters in cardiovascular diseases: An early indicator of prognosis? [DOI]
20. 20 Hypertension Is a Risk Factor for Several Types of Heart Disease: Review of Prospective Studies [DOI]
21. 21 Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio are Predictors of Heart Failure [DOI]
22. 22 Platelet count is associated with cardiovascular disease, cancer and mortality: A population-based cohort study [DOI]
23. 23 Usefulness of Neutrophil-to-Lymphocyte Ratio in Risk Stratification of Patients With Advanced Heart Failure [DOI]
24. 24 Aspartate aminotransferase and cardiovascular disease—a narrative review [DOI]
25. 25 Elements of the complete blood count associated with cardiovascular disease incidence: Findings from the EPIC-NL cohort study [DOI]
26. 26 Association of the Aspartate Aminotransferase to Alanine Aminotransferase Ratio with BNP Level and Cardiovascular Mortality in the General Population: The Yamagata Study 10-Year Follow-Up [DOI]
27. 27 Association of mean platelet volume and platelet count with the development and prognosis of ischemic and hemorrhagic stroke [DOI]
28. 28 The prognostic role of platelet-to-lymphocyte ratio in patients with acute heart failure: A cohort study [DOI]
29. 29 Relation of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio with coronary artery disease severity in patients undergoing coronary angiography [DOI]
30. 30 The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk assessment [DOI]
31. 31 Combined Usefulness of the Platelet-to-Lymphocyte Ratio and the Neutrophil-to-Lymphocyte Ratio in Predicting the Long-Term Adverse Events in Patients Who Have Undergone Percutaneous Coronary Intervention with a Drug-Eluting Stent [DOI]
32. 32 AST/ALT ratio predicts the functional severity of chronic heart failure with reduced left ventricular ejection fraction [DOI]
33. 33 Preoperative neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are associated with major adverse cardiovascular and cerebrovascular events in coronary heart disease patients undergoing non-cardiac surgery [DOI]
34. 34 Cardiovascular risk assessment tools in Asia
35. 35 Racial/Ethnic Differences in Hypertension Prevalence, Treatment, and Control for Outpatients in Northern California 2010–2012 [DOI]
36. 36 Non‐alcoholic fatty liver disease is associated with cardiovascular disease risk markers [DOI]
37. 37 Elevated liver enzymes and cardiovascular mortality: a systematic review and dose–response meta-analysis of more than one million participants [DOI]
38. 38 Prognostic value of neutrophil-to-lymphocyte ratio in pulmonary arterial hypertension [DOI]
39. 39 Clinical utility of red blood cell distribution width in inflammatory and non‐inflammatory joint diseases [DOI]
40. 40 Perfil lipídico e fatores de risco para doenças cardiovasculares em estudantes de medicina [DOI]
41. 41 Severe Neutropenia in Dengue Patients: Prevalence and Significance [DOI]
42. 42 The association between AST/ALT ratio and all-cause and cardiovascular mortality in patients with hypertension [DOI]
43. 43 Knowledge of risk factors for diabetes or cardiovascular disease (CVD) is poor among individuals with risk factors for CVD [DOI]
44. 44 INTERPRETATION OF THE COMPLETE BLOOD COUNT [DOI]
45. 45 Risk estimates of cardiovascular diseases in a Sri Lankan community [DOI]
46. 46 Increased neutrophil to lymphocyte ratio predicts myocardial injury in patients undergoing non-cardiac surgery [DOI]
47. 47 Epidemiologic studies targeting primary cardiovascular disease prevention in South Asia [DOI]
48. 48 Orientation diagnostique devant une lymphopénie [DOI]
49. 49 A young woman with rigors and abdominal pain [DOI]
50. 50 Development and Distortion of Malaysian Public- Private Partnerships: Patronage, Privatised Profits and Pitfalls DOI: 10.1111/j.1467- 8500.2009.00655.x [DOI]
51. 51 Lipids in Atherosclerosis: Pathophysiology and the Role of Calculated Lipid Indices in Assessing Cardiovascular Risk in Patients with Hyperlipidemia [DOI]
52. 52 Red Blood Cell Distribution Width as Novel Biomarker in Cardiovascular Diseases: A Literature Review [DOI]
53. 53 Cost analysis of treating cardiovascular diseases in a super-specialty hospital [DOI]
54. 54 Evaluation of cardiovascular diseases risk calculators for CVDs prevention and management: scoping review [DOI]
55. 55 Absolute lymphocyte count as a predictor of mortality and readmission in heart failure hospitalization [DOI]
56. 56 High AST/ALT Ratio Is Associated with Cardiac Involvement in Acute COVID-19 Patients [DOI]

Cited by 2

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.